PL348758A1 - Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system - Google Patents

Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Info

Publication number
PL348758A1
PL348758A1 PL99348758A PL34875899A PL348758A1 PL 348758 A1 PL348758 A1 PL 348758A1 PL 99348758 A PL99348758 A PL 99348758A PL 34875899 A PL34875899 A PL 34875899A PL 348758 A1 PL348758 A1 PL 348758A1
Authority
PL
Poland
Prior art keywords
nervous system
central nervous
treating diseases
azabicycloalkane derivatives
substituted
Prior art date
Application number
PL99348758A
Other languages
English (en)
Inventor
Rainer Munschauer
Gerd Steiner
Gerhard Gross
Martin Traut
Liliane Unger
Hans-Juergen Teschendorf
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of PL348758A1 publication Critical patent/PL348758A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL99348758A 1998-11-24 1999-11-12 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system PL348758A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (de) 1998-11-24 1998-11-24 Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht
PCT/EP1999/008734 WO2000030639A1 (de) 1998-11-24 1999-11-12 Verwendung von n-substituierten azabicycloalkan-derivaten zur behandlung von erkrankungen des zentralen nervensystems

Publications (1)

Publication Number Publication Date
PL348758A1 true PL348758A1 (en) 2002-06-03

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99348758A PL348758A1 (en) 1998-11-24 1999-11-12 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Country Status (21)

Country Link
EP (1) EP1133293A1 (xx)
JP (1) JP2002530333A (xx)
KR (1) KR20010080535A (xx)
CN (1) CN1328455A (xx)
AR (1) AR021502A1 (xx)
AU (1) AU1775300A (xx)
BG (1) BG105549A (xx)
BR (1) BR9915589A (xx)
CA (1) CA2352526A1 (xx)
CZ (1) CZ20011796A3 (xx)
DE (1) DE19854147A1 (xx)
HK (1) HK1040933A1 (xx)
HR (1) HRP20010472A2 (xx)
HU (1) HUP0104416A3 (xx)
IL (1) IL143181A0 (xx)
NO (1) NO20012538L (xx)
PL (1) PL348758A1 (xx)
SK (1) SK7112001A3 (xx)
TR (1) TR200101476T2 (xx)
WO (1) WO2000030639A1 (xx)
ZA (1) ZA200103976B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0519013A2 (pt) 2004-12-13 2009-11-03 Lilly Co Eli composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
BR112015016992A8 (pt) * 2013-01-15 2018-01-23 Novartis Ag uso de agonistas do receptor alfa 7 nicotínico de acetilcolina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
CA2352526A1 (en) 2000-06-02
KR20010080535A (ko) 2001-08-22
NO20012538D0 (no) 2001-05-23
HRP20010472A2 (en) 2003-04-30
JP2002530333A (ja) 2002-09-17
DE19854147A1 (de) 2000-05-25
CZ20011796A3 (cs) 2002-05-15
BR9915589A (pt) 2001-08-07
SK7112001A3 (en) 2001-12-03
AU1775300A (en) 2000-06-13
BG105549A (en) 2001-12-29
HUP0104416A3 (en) 2002-11-28
ZA200103976B (en) 2002-05-16
TR200101476T2 (tr) 2001-10-22
HK1040933A1 (zh) 2002-06-28
IL143181A0 (en) 2002-04-21
WO2000030639A1 (de) 2000-06-02
AR021502A1 (es) 2002-07-24
HUP0104416A2 (hu) 2002-04-29
EP1133293A1 (de) 2001-09-19
NO20012538L (no) 2001-07-04
CN1328455A (zh) 2001-12-26

Similar Documents

Publication Publication Date Title
GB2305605B (en) Pipecolic acid derivatives for the treatment of neurological disorders
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
IL139591A0 (en) Combination therapy for treatment of bipolar disorders
IL138129A (en) Composition for therapy of estrogen-associated disorders
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
PL350679A1 (en) Derivatives of 1-arenosulphonyl-2-arylpyrolydine and piperidine for treating central nervous system disorders
IL141263A0 (en) Methods for treatment of neurological disorders
SI0908458T1 (sl) Substituirani piridilmetilpiperazinovi in piperidinovi derivati, njihova priprava in njihova uporaba za zdravljenje motenj centralnega zivcnega sistema (cns)
EP1207874A4 (en) METHOD FOR THE TREATMENT OF PROLIFERATIVE DISEASES
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
EE200000391A (et) Triasiiniühendid kesknärvisüsteemihäirete raviks
HUP0104701A3 (en) 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders and medicaments containing the compounds
ATE256126T1 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
HK1038510B (zh) 使用神經營養因子興奮劑治療眼神經變性疾病
IL143181A0 (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
HUP9902167A3 (en) Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system
HUP0100365A3 (en) Combination therapy for the treatment of aids
IL136949A0 (en) 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
PT1011678E (pt) Utilização de mecamilamina para o tratamento de perturbações neuropsiquiátricas responsivas à nicotina.
GB0010496D0 (en) Treatment of conditions of the central nervous system
GB9901808D0 (en) Drugs for treatment of psychiatric and brain disorders
GB9821610D0 (en) Treatment of neuropsychiatric disorders
GB9923551D0 (en) Treatment of neuropsychiatric disorders
SI1133290T1 (en) Use of inhibitors of acetylcholinesterase for the treatment of deliriums
UA25221A (uk) Спосіб лікуваhhя розладів цеhтральhої hервової системи

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)